Trospium chloride

Drug Profile

Trospium chloride

Alternative Names: IP 631; Regurin; Sanctura

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Madaus
  • Class Antispasmodics; Benzhydryl compounds; Benzilates; Esters; Nortropanes; Small molecules; Spiro compounds
  • Mechanism of Action Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Overactive bladder

Most Recent Events

  • 16 Aug 2010 Generic equivalent approved in USA for overactive bladder
  • 18 Oct 2007 Esprit Pharma has been acquired by Allergan
  • 19 Jul 2007 Madaus has been acquired by Rottapharm
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top